Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

FATE

Fate Therapeutics Inc

Jun 18 • 04:00PM ET

2.09

+0.13 6.63 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: ALLO CCCC ALXO BCYC CLLS FHTX CHRS IMRX REPL ZNTL

| Held by: VTI IWM VXF IWN VTWO SCHA VHT IWC PRFZ VTWV

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.09	Insider Own	5.16%	Shs Outstand	116.27M	Perf Week	6.09%
Market Cap	243.61M	Forward P/E	-	EPS next Y	-1.02	Insider Trans	-1.16%	Shs Float	110.55M	Perf Month	10.58%
Enterprise Value	145.57M	PEG	-	EPS next Q	-0.27	Inst Own	60.84%	Short Float	9.68%	Perf Quarter	93.52%
Income	-129.91M	P/S	38.55	EPS this Y	5.93%	Inst Trans	11.30%	Short Ratio	3.69	Perf Half Y	91.74%
Sales	6.32M	P/B	1.35	EPS next Y	5.34%	ROA	-38.01%	Short Interest	10.70M	Perf YTD	112.70%
Book/sh	1.55	P/C	1.39	EPS next 5Y	2.76%	ROE	-55.50%	52W High	2.88 -27.43%	Perf Year	72.73%
Cash/sh	1.50	P/FCF	-	EPS past 3/5Y	26.67% 11.42%	ROIC	-51.60%	52W Low	0.91 129.67%	Perf 3Y	-62.54%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-58.98% -26.71%	Gross Margin	-97.69%	Volatility	10.08% 11.12%	Perf 5Y	-97.39%
Dividend TTM	-	EV/Sales	23.03	EPS Y/Y TTM	26.97%	Oper. Margin	-2207.47%	ATR (14)	0.22	Perf 10Y	24.40%
Dividend Ex-Date	-	Quick Ratio	5.85	Sales Y/Y TTM	-52.64%	Profit Margin	-2056.79%	RSI (14)	51.89	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.85	EPS Q/Q	18.19%	SMA20	-4.41%	Beta	2.58	Target Price	5.41
Payout	-	Debt/Eq	0.43	Sales Q/Q	-20.26%	SMA50	12.03%	Rel Volume	1.42	Prev Close	1.96
Employees	161	LT Debt/Eq	0.40	Earnings	May 13 BMO	SMA200	54.63%	Avg Volume	2.90M	Price	2.09
IPO	Oct 01, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	7.14% -12.93%	Trades		Volume	4,114,480	Change	6.63%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)